Anderson Karen S
Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Cancer Invest. 2009 May;27(4):361-8. doi: 10.1080/07357900802574421.
The goal of cancer vaccines and immunotherapies is to train the immune system to recognize cancer cells and destroy them. Immune responses play a dynamic role in the development of cancers, from immunosurveillance to immune escape; from in situ immune dysregulation to metastatic spread. The systematic identification and targeting of molecules involved in the immune response has led to a wide variety of potential immunotherapeutic targets for the treatment of breast cancer. Extraordinary advances in molecular immunology have led to a detailed understanding of tumor antigens, antigen presentation, innate immunity, cytokine and chemokine pathways, and immunoregulation. Many of these vaccine therapies are already in clinical development. It is the rational and rapid translation of these scientific discoveries into effective therapies for patients with breast cancer that poses the greatest challenge, and opportunity, to realize the potential of tumor vaccine therapy for breast cancer.
癌症疫苗和免疫疗法的目标是训练免疫系统识别并摧毁癌细胞。免疫反应在癌症发展过程中发挥着动态作用,从免疫监视到免疫逃逸;从原位免疫失调到转移扩散。对免疫反应中涉及分子的系统识别和靶向作用,已产生了多种用于治疗乳腺癌的潜在免疫治疗靶点。分子免疫学的非凡进展使人们对肿瘤抗原、抗原呈递、固有免疫、细胞因子和趋化因子途径以及免疫调节有了详细的了解。其中许多疫苗疗法已处于临床开发阶段。将这些科学发现合理、快速地转化为针对乳腺癌患者的有效疗法,是实现肿瘤疫苗治疗乳腺癌潜力所面临的最大挑战,也是最大机遇。